CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis

FOXP3型 CD8型 肿瘤浸润淋巴细胞 调节性T细胞 流式细胞术 癌症 肿瘤微环境 医学 癌症研究 免疫组织化学 免疫系统 T细胞 免疫学 白细胞介素2受体 内科学
作者
Fangxuan Li,Yao Sun,Jinchao Huang,Wengui Xu,Juntian Liu,Zhi Yong Yuan
出处
期刊:Cancer Medicine [Wiley]
卷期号:8 (17): 7330-7344 被引量:84
标识
DOI:10.1002/cam4.2596
摘要

Abstract Background The tumor microenvironment represents an abnormal niche containing numerous factors, such as T cells, dendritic cells (DCs), regulatory T cells (Tregs), and indoleamine 2,3‐dioxygenase (IDO), involved in maintaining immune homeostasis and tolerance. All these factors may influence the choice of therapy and the clinical outcomes. Methods Flow cytometry was performed to identify CD4+/CD8 + T cells and DCs, and immunohistochemistry was used to evaluate IDO and Forkhead Box P3 (Foxp3) expression; these experiments were performed in order to explore the clinical and prognostic significance of CD4/CD8 + T cells, DCs, Tregs, and IDO expression in gastric carcinoma. Results Smaller tumor size was correlated with higher expression levels of peripheral CD4 + T cells ( P = .003) and CD8 + T cells ( P = .002), and lower IDO expression ( P = .044) in tumors. Well‐differentiated gastric carcinomas displayed higher peripheral ( P = .029) and tumor‐infiltrating CD4 + T cell ( P = .009) populations and a higher tumor‐infiltrating DC1/DC2 ratio ( P = .048). Gastric cancer in the early T stages exhibited higher populations of peripheral DC2s ( P = .044) and a higher tumor‐infiltrating DC1/DC2 ratio ( P = .012). Gastric cancer at the N0 stage had lower tumor‐infiltrating DC2s ( P = .032) and a higher DC1/DC2 ratio ( P = .037). IDO expression was positively correlated with tumor‐infiltrating Foxp3 + Tregs ( P < .001) as well as DC2s ( P < .001), whereas it was negatively correlated with the tumor‐infiltrating CD4/CD8 + T cell ratio ( P = .023). Tumor‐infiltrating Foxp3 + Treg was positively correlated with tumor‐infiltrating DC2s ( r 2 = 0.772; P < .001). At T, N, and TNM stages, the expression levels of peripheral DC2s, tumor‐infiltrating DC1/DC2 ratios, Foxp3 + Tregs, and IDO were significantly correlated with prognosis ( P < .05). The T stage and peripheral DC2s were significant risk factors for overall survival. Conclusion Immunocompetent cells and humoral immune factors, including DC2s, CD4+/CD8 + T cells, Foxp3 + Tregs, and IDO, interact with each other to compose a complex community of tumor immune microenvironment, ultimately affecting tumor progression and survival of gastric cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
宋浩奇完成签到,获得积分10
1秒前
2秒前
2秒前
王康发布了新的文献求助10
3秒前
隐形曼青应助Daniel2010采纳,获得10
3秒前
DY驳回了英姑应助
4秒前
精灵夜雨完成签到,获得积分10
4秒前
宋浩奇发布了新的文献求助10
5秒前
iNk应助欧皇采纳,获得10
5秒前
5秒前
5秒前
Tyler发布了新的文献求助10
7秒前
7秒前
科研通AI6应助sifLiu采纳,获得10
7秒前
7秒前
害羞彩虹完成签到,获得积分20
8秒前
没有名称完成签到,获得积分10
8秒前
8秒前
王康完成签到,获得积分10
9秒前
9秒前
冷傲迎梦发布了新的文献求助10
10秒前
搜集达人应助111版采纳,获得10
12秒前
wanwusheng完成签到,获得积分10
14秒前
WUJIAYU完成签到,获得积分10
15秒前
17秒前
suger完成签到,获得积分10
18秒前
21秒前
蔺蔺发布了新的文献求助10
22秒前
22秒前
23秒前
24秒前
Yu完成签到,获得积分20
24秒前
废寝忘食发布了新的文献求助10
25秒前
liliuuuuuuuu发布了新的文献求助10
27秒前
ybheart发布了新的文献求助10
28秒前
孙敬涵完成签到,获得积分10
28秒前
Tengami完成签到 ,获得积分10
29秒前
量子星尘发布了新的文献求助10
29秒前
宽宽完成签到,获得积分10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 851
The International Law of the Sea (fourth edition) 800
A Guide to Genetic Counseling, 3rd Edition 500
Synthesis and properties of compounds of the type A (III) B2 (VI) X4 (VI), A (III) B4 (V) X7 (VI), and A3 (III) B4 (V) X9 (VI) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5415163
求助须知:如何正确求助?哪些是违规求助? 4531822
关于积分的说明 14130468
捐赠科研通 4447366
什么是DOI,文献DOI怎么找? 2439667
邀请新用户注册赠送积分活动 1431779
关于科研通互助平台的介绍 1409365